Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07492303 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 25, 2026 (before its estimated July 10, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
the safety and tolerability of different dosages of adsorbed acellular pertussis (two-component) diphtheria-tetanus combined vaccine
Trial Details
NCT Number NCT07492303
Lead Sponsor Changchun BCHT Biotechnology Co.
Conditions
(from sponsor)		 Pertussis (Whooping Cough), Diphtheria, Tetanus
Related terms Diphtheria, Tetanus, Whooping Cough
Enrollment 96 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov